Article Details

ACTG launches phase 1 combination HIV cure study

Retrieved on: 2021-06-10 12:45:00

Tags for this article:

Click the tags to see associated articles and topics

ACTG launches phase 1 combination HIV cure study. View article details on hiswai:

Excerpt

In pre-clinical and clinical research, N-803 (an IL-15 superagonist) has exhibited three activities that may help the immune system eliminate HIV ...

Article found on: www.eurekalert.org

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up